Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Current Opinion in Lipidology|October 7, 2022
New algorithms for treating homozygous familial hypercholesterolemiaTycho R Tromp, Marina CuchelCurrent Atherosclerosis Reports|March 17, 2016
Recent Developments in Gene Therapy for Homozygous Familial HypercholesterolemiaEzim Ajufo, Marina CuchelAtherosclerosis|February 1, 2023
Gene editing for dyslipidemias: New tools to "cut" lipidsSylvia Stankov, Marina CuchelCurrent Opinion in Lipidology|April 26, 2020
Homozygous familial hypercholesterolemia: what treatments are on the horizon?Archna Bajaj, Marina CuchelJournal of Atherosclerosis and Thrombosis|April 25, 2022
Advancements in the Treatment of Homozygous Familial HypercholesterolemiaArchna Bajaj, Marina CuchelCurrent Opinion in Lipidology|February 9, 2021
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectivesArjen J Cupido, Tycho R Tromp, G Kees HovinghCurrent Opinion in Lipidology|April 19, 2013
Microsomal transfer protein inhibition in humansMarina Cuchel, Daniel J RaderThescientificworldjournal|June 14, 2003
The role of high density lipoproteins in thrombosisMarina Cuchel, Daniel J RaderCurrent Opinion in Lipidology|April 24, 2020
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?Laurens F Reeskamp, Tycho R Tromp, Erik S G StroesExpert Opinion on Investigational Drugs|May 1, 2020
Gene-based therapy in lipid management: the winding road from promise to practiceTycho R Tromp, Erik S G Stroes, G Kees HovinghPageof 10